San Diego, CA -- (SBWIRE) -- 01/09/2018 -- An investigation was announced for investors of Abeona Therapeutics Inc (NASDAQ:ABEO) shares over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Abeona Therapeutics Inc (NASDAQ:ABEO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Abeona Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.

Dalas, TX based Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. Abeona Therapeutics Inc reported that its annual Total Revenue declined from $1.04 million in 2015 to $0.89 million in 2016 and that its Net Loss increased from $14.53 million in 2015 to $21.87 million in 2016.

On January 8, 2018, NASDAQ:ABEO shares closed at $15.25 per share.

Those who purchased shares of Abeona Therapeutics Inc (NASDAQ:ABEO), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com